Sep 1, 2014
USFDA grants Qualified Infectious Disease Product status to two Wockhardt drugs
USFDA grants Qualified Infectious Disease Product status to two Wockhardt drugs
31 Aug, 2014, NEW DELHI: Drug maker WockhardtBSE -1.83 % today said that two of its anti-infective drugs have received Qualified Infectious Disease Product (QIDP) status from the US health regulator.Two drugs – WCK 771 and WCK 2349 – have received QIDP status, which allows fast-track review of the drug application by the US Food and Drug Administration (USFDA), Wockhardt said in a statement.…
View On WordPress